CoupledCAR® Platform Pipeline

Robust pipeline addressing large solid tumor markets with high unmet medical need​

• Rapid proof of concept (PoC) and clinical data from China IRB-approved trials¹​
• US clinical trials to validate China-IRB trials and provide further information in US patient population